Stella, a Chicago, IL-based company which specializes in comprehensive treatment for post traumatic stress, anxiety, stress, depression, traumatic brain injury, and Long COVID, raised $7M in funding.
The funds were raised from Sterling Partners.
The company intends to use the funds to advance its mental health research and open locations across the US and abroad.
Founded in 2020 and led by CEO Philippe Sanchez, Stella is committed to delivering mental health care through responsible innovation. Its team of board certified physicians, psychiatric nurse practitioners, psychologists, and tireless advocates provide comprehensive care across 35+ USA locations, as well as in Israel and Australia. The company has also introduced multiple new treatment protocols and modalities, including Ketamine Infusion Therapy, and the recently awarded SOF Protocol – a treatment that combines the benefits of ketamine and DSR (Dual Sympathetic Reset).
Stella, which has treated over 6,000 patients to date, also unveiled its new flagship facility in Chicago, which will serve as a hub for innovative treatments, research, and medical training – including hosting clinical trials and uncovering effective, science-backed treatment protocols and methodologies.
FinSMEs
09/05/2023